HYBRID EVENT
September 14-16, 2026 | Rome, Italy
GPMB 2026

Eco-innovative formulation of Folic Acid Coated Pea Pods-based Phytosomes (FPPbP): A sustainable approach against cancer

Manas Jyoti Kapil, Speaker at Plant Biology Conferences
Assam Don Bosco University, India
Title : Eco-innovative formulation of Folic Acid Coated Pea Pods-based Phytosomes (FPPbP): A sustainable approach against cancer

Abstract:

Cancer treatment continues to face challenges such as poor drug targeting, side effects, and limited bioavailability of therapeutic agents. In response, this study explores a sustainable and innovative approach by developing folic acid–coated phytosomes derived from pea pod extracts. Pea pods, often considered agricultural waste, are rich in bioactive phytochemicals with potential anticancer properties, making them an eco-friendly and cost-effective resource. The formulation of phytosomes enhances the stability and absorption of these plant-derived compounds, while folic acid coating facilitates targeted delivery to cancer cells, which commonly overexpress folate receptors. This dual strategy not only improves therapeutic efficiency but also minimizes damage to healthy tissues. The prepared system will be evaluated for its physicochemical characteristics, stability, and in vitro anticancer activity. Hypothesis is made that the formulated phytosomes will exhibit improved bioavailability, controlled release behavior, and promising cytotoxic effects against cancer cell lines compared to conventional extracts. The use of biodegradable materials and waste-derived resources further, will highlight the environmental and economic benefits of this approach. Overall, this study presents a human-centered and environmentally responsible strategy that integrates green chemistry with advanced drug delivery systems that could serve as a potential candidate for safer and more effective cancer therapy, while also promoting sustainability in pharmaceutical development.

Biography:

Dr. Manas Jyoti Kapil, possesses a robust academic and professional profile that establishes high institutional trust, currently serving as an Associate Professor at the Institute of Pharmacy, Assam Don Bosco University with a Ph.D. and M.Pharm qualification. His specialized expertise in the formulation of dosage forms, nano-formulations, and vesicular drug delivery aligns with advanced pharmaceutical research needs, further evidenced by his recent high-impact publications (Impact Factor up to 4.9) in areas such as diabetic wound hydrogels and targeted breast cancer treatment. Dr. Kapil has a proven track record of managing significant research funding, having served as a Principal Investigator (PI) and Co-PI on projects funded by the Ministry of Health & Family Welfare (DHR-HRD) totaling over Rs. 50 Lakhs. His consistent research output and experience in leading eco-innovative and sustainable formulation projects provide strong evidence of his capability as a researcher.

Watsapp